Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Insulin Delivery Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.
'Insulin Delivery Pipeline Report' provides comprehensive information about the Insulin Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Insulin delivery devices are used to inject measured doses of insulin through the skin and into the fatty tissues below.
Scope
- Extensive coverage of the Insulin Delivery under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Insulin Delivery and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Insulin Delivery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Insulin Delivery Overview
3 Products under Development
3.1 Insulin Delivery - Pipeline Products by Stage of Development
3.2 Insulin Delivery - Pipeline Products by Segment
3.3 Insulin Delivery - Pipeline Products by Territory
3.4 Insulin Delivery - Pipeline Products by Regulatory Path
3.5 Insulin Delivery - Pipeline Products by Estimated Approval Date
3.6 Insulin Delivery - Ongoing Clinical Trials
4 Insulin Delivery - Pipeline Products under Development by Companies
4.1 Insulin Delivery Companies - Pipeline Products by Stage of Development
4.2 Insulin Delivery - Pipeline Products by Stage of Development
5 Insulin Delivery Companies and Product Overview
6 Insulin Delivery- Recent Developments
7 Appendix
A selection of companies mentioned in this report includes
- Abbott Diabetes Care Inc
- Aerami Therapeutics Inc
- Alshifa Medical Syringes Manufacturing Co Ltd
- American Chemical Society
- AMF Medical SA
- Amrita Vishwa Vidyapeetham
- Andain, Inc
- Animas Corp
- ASTI Corp
- Avecho Biotechnology Ltd
- Bigfoot Biomedical Inc
- Biocon Ltd
- Cambridge Consultants Ltd
- Cellnovo Ltd (Inactive)
- Companion Medical Inc
- ConvaTec Group Plc
- Debiotech SA
- Defymed SAS
- Dermisonics Inc
- Eli Lilly and Co
- Embecta Corp
- Emperra GmbH E-Health Technologies
- EOFlow Co Ltd
- Erech Finance Cahalacha Ltd
- GO-Pen ApS
- Hospira Inc
- Houston Methodist Research Institute
- Imagine Medical Device Inc.
- InsuLenz
- Insulet Corp
- Iowa State University
- Kailian Medical Technology Co Ltd
- LifeScan Inc
- MannKind Corp
- Medical International Technologies (Mit Canada) Inc
- Medicsensors SL
- MedPro Safety Products, Inc.
- MedSolve Technologies, Inc.
- Medtronic MiniMed Inc
- Medtronic Plc
- MicroPort Scientific Corp
- MicroTech Medical Co Ltd
- Modular Medical Inc
- NanoDerma Ltd
- nGageIT Digital Health Inc
- Nitto Denko Corp
- North Carolina State University
- Novo Nordisk AS
- NuGen Medical Devices Inc
- Pennsylvania State University
- Perikinetics Inc
- Phluid Corporation
- PhysioLogic Devices Inc
- PositiveID Corp
- Prometheon Pharma LLC
- Qlibrium Inc
- Sanofi
- SFC Fluidics LLC
- Sooil Development Co., Ltd.
- Spring Health Solutions Ltd.
- Tandem Diabetes Care Inc
- TempraMed Israel Ltd
- Thermalin Inc
- Transdermal Specialties Inc
- Triple Jump Israel Ltd
- University of KwaZulu-Natal
- University of Limerick
- University of Massachusetts Amherst
- University of Missouri-Kansas City
- University of North Carolina
- University of Toronto
- Univlabs Technologies Pvt Ltd
- Unomedical a/s
- Valeritas Inc
- ViCentra BV
- Vigmed Holding AB
- Washington University School of Medicine
- Ypsomed Holding AG
- Zealand Pharma AS
- Zenomics Inc
For more information about this report visit https://www.researchandmarkets.com/r/a29s04
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
